Neurodegeneration Initiatives

Biomarkers for Neurodegeneration
Closed December 9, 2006 - Seventeen awards made in FY07.
  • Unless neurodegenerative diseases can be diagnosed and treated at an early stage, irreversible cellular damage may occur.
  • This initiative supports the development of biomarkers that can be used for risk assessment, diagnosis, and post-diagnosis monitoring of disease.
Therapeutics Delivery for Neurodegenerative Diseases
Closed December 9, 2006 - Eleven awards made in FY07.
  • Despite promising strategies for treating neurodegenerative disease - e.g., engineered proteins, antibody-based "vaccines," and RNA interference - delivery of these agents to the nervous system remains a challenge.
  • This initiative supports the development of delivery tools, including new viral vectors and standardized cell lines.
  • Provides interdisciplinary training in neurodegeneration research at the postdoctoral level.
  • Enables established investigators to acquire interdisciplinary perspectives and skills in neurodegeneration research through short-term mentorship and training, typically during an academic sabbatical.